Evidence map›Paper›PMID 22812510›Full record

ReviewThe FEBS journal2013

Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling.

Christopher J Caunt, Stephen M Keyse

Open access · bronzeAbstract readReview
In one paragraph

Review in The FEBS journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 315 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
315citing papers in PubMed, 1 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

315 citing papers in PubMed, 1 synthesis or guideline pooled it, 548 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Microorganisms · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. MAP kinase phosphatases in metabolic diseases.Trends in endocrinology and metabolism: TEM · 2026
    Review
  17. Article
  18. Review
  19. Article
  20. The pERKs of temporal order memory in mice.Frontiers in molecular neuroscience · 2026
    Article

255 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Christopher J CauntDepartment of Biology and Biochemistry, University of Bath, Bath, UK. c.caunt@bath.ac.uk
Stephen M Keyse
Ninewells Hospital · GBUniversity of Bath · GB

Funding

Cancer Research UK 12053Cancer Research UK C8227/A12053
6 · The paper itself

Abstract

Dual-specificity MAP kinase phosphatases (MKPs) provide a complex negative regulatory network that acts to shape the duration, magnitude and spatiotemporal profile of MAP kinase activities in response to both physiological and pathological stimuli. Individual MKPs may exhibit either exquisite specificity towards a single mitogen-activated protein kinase (MAPK) isoform or be able to regulate multiple MAPK pathways in a single cell or tissue. They can act as negative feedback regulators of MAPK activity, but can also provide mechanisms of crosstalk between distinct MAPK pathways and between MAPK signalling and other intracellular signalling modules. In this review, we explore the current state of knowledge with respect to the regulation of MKP expression levels and activities, the mechanisms by which individual MKPs recognize and interact with different MAPK isoforms and their role in the spatiotemporal regulation of MAPK signalling.

Indexed as

MAP Kinase Signaling SystemCell NucleusCytoplasmDual Specificity Phosphatase 6Dual-Specificity PhosphatasesHumansMitogen-Activated Protein Kinase PhosphatasesMitogen-Activated Protein KinasesSubstrate SpecificityDual Specificity Phosphatase 6Dual-Specificity PhosphatasesDUSP5 protein, humanDUSP6 protein, humanMitogen-Activated Protein Kinase PhosphatasesMitogen-Activated Protein Kinases

Identifiers

PMID22812510
PMCPMC3594966
OpenAlexW1965790167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.